# PK of BDP/FF/GB Single-inhaler Triple Therapy in Japanese vs. Caucasians

> **NCT03859414** · PHASE1 · COMPLETED · sponsor: **Chiesi Farmaceutici S.p.A.** · enrollment: 32 (actual)

## Conditions studied

- Asthma
- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Therapeutic Dose 1
- **DRUG:** Therapeutic Dose 2
- **DRUG:** Supra-therapeutic Dose
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03859414
- **Lead sponsor:** Chiesi Farmaceutici S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-18
- **Primary completion:** 2019-07-24
- **Final completion:** 2019-07-24
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2021-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03859414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03859414, "PK of BDP/FF/GB Single-inhaler Triple Therapy in Japanese vs. Caucasians". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03859414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*